Adults with MS had lower annualized relapse rates with diroximel fumarate vs. dimethyl fumarate treatment at 1 and 2 years, ...

After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active ...

Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

Ecopipam maintains tic improvement, phase III study shows ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

As with many types of cancer, acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, can come back after successful treatment. This is known as a relapse. Relapses can cause you ...

Teclistamab (Tecvayli; Johnson & Johnson) appears poised to move into earlier lines of care as a monotherapy, as bispecific antibodies made big news in the treatment of blood cancers and disorders on ...

Helping a loved one manage their addiction doesn’t stop in recovery. With nearly 28 million Americans who report they are currently recovering, addiction requires the same long-term care and ...